Senate FDA Appropriations Rival House, But Partisan Roadblock Looms
This article was originally published in The Rose Sheet
Senate and House bills propose $2.552 billion and $2.485 billion in direct appropriations for FDA in fiscal 2014, but partisan battles in Congress make a continuing resolution to start fiscal 2014 seem inevitable.
You may also be interested in...
House leadership plans a comprehensive bill to undo sequestration for the government as a whole, but Republican Robert Aderholt, who chairs the House subcommittee that originates appropriations for FDA, says he is willing to work with Senate appropriators in conference on a fix specific to the agency’s user fees.
Pink Sheet Podcast: Understanding the White House Coronavirus Treatment Announcement, US FDA Postpones Domestic Inspections, Biologics Transition Day Arrives
Pink Sheet editor and reporters discuss the pending trials of chloroquine for use against coronavirus, expanded access for remdesivir, and the official move of several biologics from regulation as drugs to regulation as biologics.
Pink Sheet Podcast: US FDA Announces Coronavirus Containment Strategy, Issues Updated Type 2 Diabetes Guidance
Pink Sheet reporter and editor consider the fall-out from the FDA decision to cancel meetings and postpone inspections due to the coronavirus pandemic, as well as look at the new cardiovascular recommendations for Type 2 diabetes drug development.